Medefer, a company focused on reducing patient waiting times, has raised £10million in new funding, led by private investment firm Nickleby Capital.
The virtual healthcare provider has raised the funding to support its growth plans and scale-up it’s offering that aims to digitise the entire pathway from referral to discharge.
The company was founded in 2013 by NHS consultant Dr Bahman Nedjat-Shokouhi, who still works in the NHS. The digital platform that connects GPs, consultants, and patients has been used by 20,000 patients to date. Its model aims to reduce outpatient costs by a third, and waiting lists reduced by 70%, by improving consultant capacity and creating better use of resources.
Dr Bahman Nedjat-Shokouhi, CEO of Medefer and Consultant Gastroenterologist at Whittington Hospital NHS Trust, said: “Medefer was born out of a desire to empower the NHS to deliver a radically faster, safer and more effective service from referral, through diagnosis, to treatment and discharge.”
“Our software can fundamentally transform the delivery of outpatient services. This funding round will enable us to support the NHS during its most challenging times in its 72 year history, and to continue to innovate in virtual specialist care.”
Marco Schiavo, Managing Partner, Nickleby Capital, said: “Medefer is a business whose time has come. They have a unique model with huge, growing, demand.”
“They help the NHS slash waiting lists and save money, as well as improving patient outcomes. The Medefer team is outstanding and we’re very excited about working with them to help achieve their incredible vision.”
